Answers are grounded in this paper and cite their sources.
In South America, Plasmodium vivax resistance to chloroquine was recently reported in Brazil and Bolivia. The objective of this study was to collect data on chloroquine resistance in French Guiana by associating a retrospective evaluation of therapeutic efficacy with an analysis of recurrent parasitemia from any patients. Patients with P. vivax infection, confirmed by microscopy and a body temperature of ≥37.5°C, were retrospectively identified at Cayenne Hospital between 2009 and 2015.
No takes yet. Share an insight, caveat, or question.
Musset et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: